FCGR3A and Hodgkins lymphoma: Clinical stage TandAbs include AMV564, Aphivena’s anti-CD33 × CD3 TRBA for myelodysplastic syndromes [212] and AFM13, Affimed’s NK-cell redirected anti-CD30 × CD16a candidate for Hodgkin’s lymphoma [148].